Additionally, more cell, animal and clinical sample‐based investigations are needed to further explore the potential role or clinical benefits of GAS2L1, GAS2L2 and GAS2L3 in the aetiology and pathogenesis of relevant diseases, such as tumours. The gene discussed is GAS2L2; the disease is neoplasm.